An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
Study Title
- An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
Teva Identifier
- TV48125-CNS-30068 | 2017-002441-30
ClinicalTrials.gov Identifier
- NCT03308968
Study Status
- Completed
Trial Condition(s)
- Migraine Prophylaxis
Interventions
- Drug: Fremanezumab | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 70 Years
Trial Duration
- October 13, 2017 - May 29, 2019
Phase
- Phase 3
Study Type
Interventional
